Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.351EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.351EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.351ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.351ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.351EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.351EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.351ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.351ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.243EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.243EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.243ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.243ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.243EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.243EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.243ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.243ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
R.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
R.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
R.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
R.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
R.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
R.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
R.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used